Literature DB >> 25358041

Colistin resistance superimposed to endemic carbapenem-resistant Klebsiella pneumoniae: a rapidly evolving problem in Italy, November 2013 to April 2014.

M Monaco1, T Giani, M Raffone, F Arena, A Garcia-Fernandez, S Pollini, H Grundmann, A Pantosti, G M Rossolini.   

Abstract

Consecutive non-replicate clinical isolates (n=191) of carbapenem non-susceptible Enterobacteriaceae were collected from 21 hospital laboratories across Italy from November 2013 to April 2014 as part of the European Survey on Carbapenemase-producing Enterobacteriaceae (EuSCAPE) project. Klebsiella pneumonia carbapenemase-producing K. pneumoniae (KPC-KP) represented 178 (93%) isolates with 76 (43%) respectively resistant to colistin, a key drug for treating carbapenamase-producing Enterobacteriaceae. KPC-KP colistin-resistant isolates were detected in all participating laboratories. This underscores a concerning evolution of colistin resistance in a setting of high KPC-KP endemicity.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25358041     DOI： 10.2807/1560-7917.es2014.19.42.20939

Source DB:  PubMed          Journal:  Euro Surveill        ISSN： 1025-496X


  80 in total

Review 1.  Antimicrobial resistance: a global multifaceted phenomenon.

Authors:  Francesca Prestinaci; Patrizio Pezzotti; Annalisa Pantosti
Journal:  Pathog Glob Health       Date:  2015-09-07       Impact factor: 2.894

2.  Colistin Resistance Caused by Inactivation of the MgrB Regulator Is Not Associated with Decreased Virulence of Sequence Type 258 KPC Carbapenemase-Producing Klebsiella pneumoniae.

Authors:  Fabio Arena; Lucia Henrici De Angelis; Antonio Cannatelli; Vincenzo Di Pilato; Marina Amorese; Marco Maria D'Andrea; Tommaso Giani; Gian Maria Rossolini
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191

3.  Increasing incidence of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in Belgian hospitals.

Authors:  M De Laveleye; T D Huang; P Bogaerts; C Berhin; C Bauraing; P Sacré; A Noel; Y Glupczynski
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-09-17       Impact factor: 3.267

4.  Colistin resistance mechanisms in Klebsiella pneumoniae strains from Taiwan.

Authors:  Yi-Hsiang Cheng; Tzu-Lung Lin; Yi-Jiun Pan; Yu-Ping Wang; Yi-Tsung Lin; Jin-Town Wang
Journal:  Antimicrob Agents Chemother       Date:  2015-02-17       Impact factor: 5.191

5.  Whole-genome sequencing of Klebsiella pneumoniae MDR strain isolated in a Syrian refugee.

Authors:  Silvia Angeletti; Eleonora Cella; Alessia Lai; Alessandra Lo Presti; Francesca Antonelli; Alessia Conti; Maurizio Lopalco; Silvia Spoto; Gianguglielmo Zehender; Massimo Ciccozzi
Journal:  Pathog Glob Health       Date:  2017-04-12       Impact factor: 2.894

Review 6.  Polymyxins: Antibacterial Activity, Susceptibility Testing, and Resistance Mechanisms Encoded by Plasmids or Chromosomes.

Authors:  Laurent Poirel; Aurélie Jayol; Patrice Nordmann
Journal:  Clin Microbiol Rev       Date:  2017-04       Impact factor: 26.132

7.  The Search for a Practical Method for Colistin Susceptibility Testing: Have We Found It by Going Back to the Future?

Authors:  Michael J Satlin
Journal:  J Clin Microbiol       Date:  2019-01-30       Impact factor: 5.948

8.  An outbreak of colistin-resistant Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae in the Netherlands (July to December 2013), with inter-institutional spread.

Authors:  V Weterings; K Zhou; J W Rossen; D van Stenis; E Thewessen; J Kluytmans; J Veenemans
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-06-12       Impact factor: 3.267

9.  Trimethoprim-sulfamethoxazole therapy for patients with carbapenemase-producing Klebsiella pneumoniae infections: retrospective single-center case series.

Authors:  Rita Murri; Barbara Fiori; Teresa Spanu; Ilaria Mastrorosa; Francesca Giovannenze; Francesco Taccari; Claudia Palazzolo; Giancarlo Scoppettuolo; Giulio Ventura; Maurizio Sanguinetti; Roberto Cauda; Massimo Fantoni
Journal:  Infection       Date:  2017-02-09       Impact factor: 3.553

10.  A Novel Deletion Mutation in pmrB Contributes to Concurrent Colistin Resistance in Carbapenem-Resistant Escherichia coli Sequence Type 405 of Clinical Origin.

Authors:  Ching-Hsun Wang; L Kristopher Siu; Feng-Yee Chang; Yu-Kuo Tsai; Yi-Tsung Lin; Sheng-Kang Chiu; Li-Yueh Huang; Jung-Chung Lin
Journal:  Antimicrob Agents Chemother       Date:  2020-05-21       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.